Hanwha Q CELLS' solar financing subsidiary has sold asset-backed securities (ABS) worth 350 billion KRW.

Reporter Kim Jisun / approved : 2024-05-23 03:48:15
  • -
  • +
  • 인쇄

(Photo= Yonhap news)

 

[Alpha Biz= Reporter Kim Jisun] Hanwha Solutions' Q CELLS Division (Hanwha Q CELLS) announced on the 22nd that its U.S. residential solar financing subsidiary, EnFin, has successfully completed the sale of asset-backed securities (ABS) totaling $250 million (approximately 350 billion KRW).

The company explained that this sale has diversified and stabilized EnFin's funding portfolio.

EnFin, a 100% subsidiary of Hanwha Q CELLS' U.S. branch, provides financial solutions, including installment financing for solar panel installations, to residential customers. Following a pilot project in 2022, EnFin officially launched its business in January last year.

At the end of last month, EnFin successfully sold the entire amount of ABS, which were backed by loans for residential solar installations. The issuance and transaction involved RBC Capital Markets as the lead underwriter and Banco Santander as a joint bookrunner.

This transaction has secured the necessary funds for EnFin's future financing operations, reinforcing its ability to support the growing demand for residential solar energy solutions.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Eastar Jet Founder Lee Sang-jik Acquitted in Hiring Irregularities Case on Appeal2025.11.06
SK & AWS Ulsan AI Data Center Plan Faces Delay as Ulsan Mipo Industrial Complex Excluded from Korea’s Distributed Energy Special Zone2025.11.06
Seoul High Prosecutors’ Office Launches Search of Ssangbangwool Group Subsidiary Amid Allegations of “Salmon & Soju Party” Witness Bribery in North-Korea Remittance Probe2025.11.06
National Pension Service of Korea to Support Elon Musk’s Compensation Package at Tesla; Opposes AI-Startup Investment Proposal2025.11.06
Hyundai Rotem Refutes Allegations of Supplying Faulty Locomotive Parts to Bangladesh2025.11.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사